Reddy Eleti Manila, Agrawal Manjusha, Dewani Deepika, Goyal Nidhi
Department of Obstetrics and Gynecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, IND.
Cureus. 2023 Apr 6;15(4):e37220. doi: 10.7759/cureus.37220. eCollection 2023 Apr.
Background One of the most prevalent medical issues observed during pregnancy is hypertension. Hypertensive disorders of pregnancy (HDP) and their consequences affect around 5-10% of all pregnancies globally. Preeclampsia is caused by endothelial dysfunction, which causes widespread endothelial leakage and contributes to potentially fatal consequences, such as eclampsia, placental abruption, disseminated intravascular coagulation (DIC), severe renal failure, pulmonary edema, and hepatocellular necrosis. As a result, looking for predictive markers for at-risk pregnancies that can suggest poor maternal or fetal outcomes is critical. Elevated levels of lactate dehydrogenase (LDH), as a sign of cellular damage and dysfunction, can be utilized as a biochemical marker in pregnancy-induced hypertension (PIH) as it represents the severity of the disease, and the occurrence of problems, and has also been demonstrated to co-relate with fetomaternal outcomes. Methodology A total of 230 singleton pregnant women of 28-40 weeks of gestational age were enrolled in this study. All women were divided into two groups - normotensive and preeclamptic-eclamptic groups; the second group was further divided into mild preeclampsia, severe preeclampsia, and eclampsia, based on blood pressure and the presence of proteinuria. Serum lactate dehydrogenase levels were measured in both groups and correlated with their fetomaternal outcome. Results Mean serum lactate dehydrogenase (LDH) level in eclamptic women was 1515.86 ± 754, in severely preeclamptic women was 932.2 ± 448, mild preeclamptic women were 580.5±213, while in normotensive women mean LDH level was 378.6 ± 124. The difference between normotensive and preeclamptic-eclamptic women was statistically significant (p < 0.001). The complications in the preeclamptic-eclamptic group were increased significantly in women with LDH > 800 IU/L, 600-800 IU/L compared to those who had < 600 IU/L LDH levels. Conclusions Serum LDH levels were significantly higher in women of preeclamptic-eclamptic group compared to the normotensive pregnant women. Higher LDH levels were positively correlated with disease severity and maternal complications like placental abruption, hemolysis elevated liver enzymes low platelet count (HELLP), disseminated intravascular coagulation (DIC), acute renal failure, intracranial hemorrhage, pulmonary edema, and maternal death and for fetal complications like preterm, intrauterine growth restriction (IUGR), APGAR at 1 minute < 7, APGAR at 5 minutes < 7, low birth weight (LBW), neonatal intensive care unit (NICU) admission and intrauterine fetal death (IUFD).
孕期最常见的医学问题之一是高血压。全球约5-10%的妊娠会受到妊娠高血压疾病(HDP)及其后果的影响。子痫前期由内皮功能障碍引起,会导致广泛的内皮渗漏,并引发潜在的致命后果,如子痫、胎盘早剥、弥散性血管内凝血(DIC)、严重肾衰竭、肺水肿和肝细胞坏死。因此,寻找可提示不良母胎结局的高危妊娠预测标志物至关重要。乳酸脱氢酶(LDH)水平升高作为细胞损伤和功能障碍的标志,可作为妊娠高血压(PIH)的生化标志物,因为它代表了疾病的严重程度、问题的发生情况,并且已被证明与母胎结局相关。
本研究共纳入230名孕龄为28-40周的单胎孕妇。所有孕妇分为两组——血压正常组和子痫前期-子痫组;第二组根据血压和蛋白尿情况进一步分为轻度子痫前期、重度子痫前期和子痫组。测量两组孕妇的血清乳酸脱氢酶水平,并将其与母胎结局相关联。
子痫组孕妇的血清乳酸脱氢酶(LDH)平均水平为1515.86±754,重度子痫前期孕妇为932.2±448,轻度子痫前期孕妇为580.5±213,而血压正常组孕妇的LDH平均水平为378.6±124。血压正常组与子痫前期-子痫组孕妇之间的差异具有统计学意义(p < 0.001)。与LDH水平<600 IU/L的孕妇相比,LDH>800 IU/L、600-800 IU/L的子痫前期-子痫组孕妇并发症显著增加。
子痫前期-子痫组孕妇的血清LDH水平显著高于血压正常的孕妇。较高的LDH水平与疾病严重程度及母胎并发症呈正相关,如胎盘早剥、溶血、肝酶升高、血小板减少(HELLP)、弥散性血管内凝血(DIC)、急性肾衰竭、颅内出血、肺水肿和孕产妇死亡,以及胎儿并发症如早产、胎儿生长受限(IUGR)、1分钟Apgar评分<7、5分钟Apgar评分<7、低出生体重(LBW)、新生儿重症监护病房(NICU)入院和宫内胎儿死亡(IUFD)。